Original article
Profile of patients treated with omalizumab in routine clinical practice in Spain
a Hospital de la Princesa, Madrid, Spain
b Hospital Central de la Defensa, Madrid, Spain
c Instituto Nacional de Silicosis-Hospital Universitario Central de Asturias, Facultad de Medicina, Oviedo, Spain
d Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
e Departamento Médico, Novartis farmacéutica S.A. Barcelona, Barcelona, Spain
Read
3254
Timeswas read the article
1071
Total PDF
2183
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 40 | 9 | 49 |
| 2025 11 | 188 | 37 | 225 |
| 2025 10 | 59 | 16 | 75 |
| 2025 9 | 52 | 20 | 72 |
| 2025 8 | 54 | 23 | 77 |
| 2025 7 | 83 | 5 | 88 |
| 2025 6 | 36 | 4 | 40 |
| 2025 5 | 51 | 4 | 55 |
| 2025 4 | 34 | 12 | 46 |
| 2025 3 | 28 | 4 | 32 |
| 2025 2 | 45 | 1 | 46 |
| 2025 1 | 52 | 5 | 57 |
| 2024 12 | 18 | 3 | 21 |
| 2024 11 | 23 | 4 | 27 |
| 2024 10 | 14 | 14 | 28 |
| 2024 9 | 12 | 13 | 25 |
| 2024 8 | 9 | 9 | 18 |
| 2024 7 | 12 | 4 | 16 |
| 2024 6 | 6 | 1 | 7 |
| 2024 5 | 11 | 8 | 19 |
| 2024 4 | 24 | 15 | 39 |
| 2024 3 | 34 | 5 | 39 |
| 2024 2 | 20 | 7 | 27 |
| 2024 1 | 15 | 4 | 19 |
| 2023 12 | 14 | 3 | 17 |
| 2023 11 | 12 | 4 | 16 |
| 2023 10 | 22 | 10 | 32 |
| 2023 9 | 22 | 2 | 24 |
| 2023 8 | 26 | 12 | 38 |
| 2023 7 | 14 | 4 | 18 |
| 2023 6 | 15 | 4 | 19 |
| 2023 5 | 35 | 6 | 41 |
| 2023 4 | 44 | 5 | 49 |
| 2023 3 | 22 | 9 | 31 |
| 2023 2 | 11 | 5 | 16 |
| 2023 1 | 15 | 5 | 20 |
| 2022 12 | 18 | 12 | 30 |
| 2022 11 | 19 | 9 | 28 |
| 2022 10 | 8 | 13 | 21 |
| 2022 9 | 20 | 8 | 28 |
| 2022 8 | 11 | 14 | 25 |
| 2022 7 | 13 | 8 | 21 |
| 2022 6 | 15 | 7 | 22 |
| 2022 5 | 20 | 10 | 30 |
| 2022 4 | 14 | 11 | 25 |
| 2022 3 | 20 | 8 | 28 |
| 2022 2 | 49 | 3 | 52 |
| 2022 1 | 40 | 7 | 47 |
| 2021 12 | 22 | 17 | 39 |
| 2021 11 | 40 | 18 | 58 |
| 2021 10 | 30 | 14 | 44 |
| 2021 9 | 18 | 18 | 36 |
| 2021 8 | 16 | 7 | 23 |
| 2021 7 | 11 | 18 | 29 |
| 2021 6 | 27 | 14 | 41 |
| 2021 5 | 17 | 8 | 25 |
| 2021 4 | 56 | 12 | 68 |
| 2021 3 | 37 | 10 | 47 |
| 2021 2 | 15 | 14 | 29 |
| 2021 1 | 8 | 12 | 20 |
| 2020 12 | 1 | 1 | 2 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 4 | 4 |
| 2020 7 | 0 | 1 | 1 |
| 2020 5 | 0 | 2 | 2 |
| 2020 3 | 0 | 2 | 2 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 5 | 5 |
| 2019 10 | 0 | 6 | 6 |
| 2019 9 | 0 | 5 | 5 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 0 | 20 | 20 |
| 2019 4 | 0 | 8 | 8 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 3 | 3 |
| 2018 9 | 0 | 2 | 2 |
| 2018 2 | 4 | 3 | 7 |
| 2018 1 | 12 | 4 | 16 |
| 2017 12 | 11 | 8 | 19 |
| 2017 11 | 14 | 7 | 21 |
| 2017 10 | 10 | 4 | 14 |
| 2017 9 | 10 | 12 | 22 |
| 2017 8 | 16 | 10 | 26 |
| 2017 7 | 17 | 5 | 22 |
| 2017 6 | 18 | 16 | 34 |
| 2017 5 | 21 | 13 | 34 |
| 2017 4 | 18 | 13 | 31 |
| 2017 3 | 24 | 17 | 41 |
| 2017 2 | 20 | 8 | 28 |
| 2017 1 | 4 | 1 | 5 |
| 2016 12 | 19 | 8 | 27 |
| 2016 11 | 14 | 6 | 20 |
| 2016 10 | 24 | 14 | 38 |
| 2016 9 | 11 | 13 | 24 |
| 2016 8 | 18 | 7 | 25 |
| 2016 7 | 7 | 1 | 8 |
| 2016 6 | 19 | 13 | 32 |
| 2016 5 | 10 | 18 | 28 |
| 2016 4 | 17 | 17 | 34 |
| 2016 3 | 11 | 24 | 35 |
| 2016 2 | 13 | 25 | 38 |
| 2016 1 | 15 | 24 | 39 |
| 2015 12 | 6 | 17 | 23 |
| 2015 11 | 13 | 15 | 28 |
| 2015 10 | 12 | 19 | 31 |
| 2015 9 | 9 | 5 | 14 |
| 2015 8 | 5 | 7 | 12 |
| 2015 7 | 4 | 3 | 7 |
| 2015 6 | 4 | 3 | 7 |
| 2015 5 | 4 | 5 | 9 |
| 2015 4 | 7 | 11 | 18 |
| 2015 3 | 11 | 4 | 15 |
| 2015 2 | 1 | 2 | 3 |
| 2015 1 | 0 | 2 | 2 |
| 2014 12 | 1 | 2 | 3 |
| 2014 11 | 0 | 3 | 3 |
| 2014 10 | 1 | 1 | 2 |
| 2014 9 | 2 | 4 | 6 |
| 2014 8 | 0 | 3 | 3 |
| 2014 7 | 1 | 2 | 3 |
| 2014 6 | 0 | 6 | 6 |
| 2014 5 | 0 | 10 | 10 |
| 2014 4 | 8 | 10 | 18 |
Show all
